ABVC BioPharma
ABVC
ABVC
9 hedge funds and large institutions have $377K invested in ABVC BioPharma in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.69K | |
| 2 | +$1.59K | |
| 3 | +$231 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$32 |
Top Sellers
| 1 | -$11.4K | |
| 2 | -$11K | |
| 3 | -$10K | |
| 4 |
Millennium Management
New York
|
-$10K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$537 |